Of note, the correlation between UPDRS‐III scores and levels of IGKV6‐21 was mainly driven by iPD patients (r: 0.68; P < 10−5) and much weaker in LRRK2 G2019S PD patients (r: 0.36; not significant; Fig 5B). Here, LRRK2 is linked to Parkinson disease.